Publications by authors named "Alan Heldman"

Claim this Profile
G
Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy.
Angela C Rieger, Robert J Myerburg, Victoria Florea, Bryon A Tompkins, Makoto Natsumeda, Alan W Heldman

EBioMedicine· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative access for transcatheter aortic valve replacement in older adults: A collaborative study from France and United States.
Abdulla A Damluji, Magdalena Murman, Seunghwan Byun, Mauro Moscucci, Jon R Resar, Alan W Heldman

Catheter Cardiovasc Interv· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).
Victoria Florea, Angela C Rieger, Darcy L DiFede, Jill El-Khorazaty, Makoto Natsumeda, Alan W Heldman

Circ Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration.
Makoto Natsumeda, Victoria Florea, Angela C Rieger, Bryon A Tompkins, Monisha N Banerjee, Alan W Heldman

J Am Coll Cardiol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
Samuel Golpanian, Darcy L DiFede, Aisha Khan, Ivonne Hernandez Schulman, Ana Marie Landin, Alan W Heldman

J Gerontol A Biol Sci Med Sci· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Bryon A Tompkins, Darcy L DiFede, Aisha Khan, Ana Marie Landin, Ivonne Hernandez Schulman, Alan W Heldman

J Gerontol A Biol Sci Med Sci· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT Trials.
Archana Ramireddy, Chad R Brodt, Adam M Mendizabal, Darcy L DiFede, Chris Healy, Alan W Heldman

Stem Cells Transl Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
Joshua M Hare, Darcy L DiFede, Angela C Rieger, Victoria Florea, Ana M Landin, Alan W Heldman

J Am Coll Cardiol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient and persistent conduction abnormalities following transcatheter aortic valve replacement with the Edwards-Sapien prosthesis: a comparison between antegrade vs. retrograde approaches.
Solomon J Sager, Abdulla A Damluji, Joshua A Cohen, Sachil Shah, Brian P O'Neill, Alan W Heldman

J Interv Card Electrophysiol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elective or Emergency Use of Mechanical Circulatory Support Devices During Transcatheter Aortic Valve Replacement.
Vikas Singh, Abdulla A Damluji, Rodrigo Mendirichaga, Carlos E Alfonso, Claudia A Martinez, Alan W Heldman

J Interv Cardiol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
Samuel Golpanian, Darcy L DiFede, Marietsy V Pujol, Maureen H Lowery, Silvina Levis-Dusseau, Alan W Heldman

Oncotarget· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease.
Samuel Golpanian, Ivonne H Schulman, Ray F Ebert, Alan W Heldman, Darcy L DiFede

Stem Cells Transl Med· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy.
Vasileios Karantalis, Viky Y Suncion-Loescher, Luiza Bagno, Samuel Golpanian, Ariel Wolf, Alan W Heldman

J Am Coll Cardiol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Retrograde/Antegrade Approach to Transcatheter Closure of an Aortic Paravalvular Leak.
Abdulla A Damluji, Husnu E Kaynak, Alan W Heldman

Tex Heart Inst J· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement.
Joel A Lardizabal, Conrad J Macon, Brian P O'Neill, Harit Desai, Vikas Singh, Alan W Heldman

Catheter Cardiovasc Interv· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The story of the lost needle: Foreign body embolization to the heart.
Abhijit Ghatak, Peter Baik, Rhanderson Cardoso, Jonathan Dobrinsky, Husnu Kaynak, Alan W Heldman

J Cardiol Cases· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality image guidance with Dyna-CT for transcatheter treatment of paravalvular leak of a stentless valve.
Brett Van Leer-Greenberg, Claudia A Martinez, Alan W Heldman

Catheter Cardiovasc Interv· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial).
Brian P O'Neill, Mayra Guerrero, Vinod H Thourani, Susheel Kodali, Alan Heldman

Am J Cardiol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergent Percutaneous Biventricular Support during Transcatheter Aortic Valve Replacement.
Vikas Singh, Alan Heldman

J Heart Valve Dis· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of transcatheter aortic valve embolization into the left ventricle.
Lynda Otalvaro, Abdulla Damluji, Carlos E Alfonso, Donald B Williams, Alan W Heldman

J Card Surg· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathy.
Muzammil Mushtaq, Darcy L DiFede, Samuel Golpanian, Aisha Khan, Samirah A Gomes, Alan W Heldman

J Cardiovasc Transl Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes with on-label and off-label use of the transcatheter heart valve in the United States.
Joel A Lardizabal, Conrad J Macon, Brian P O'Neill, Vikas Singh, Claudia A Martinez, Alan W Heldman

Catheter Cardiovasc Interv· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial.
Viky Y Suncion, Eduard Ghersin, Joel E Fishman, Juan Pablo Zambrano, Vasileios Karantalis, Alan W Heldman

Circ Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches.
Tanyanan Tanawuttiwat, Brian P O'Neill, Mauricio G Cohen, Orawee Chinthakanan, Alan W Heldman

J Am Coll Cardiol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.
Vasileios Karantalis, Darcy L DiFede, Gary Gerstenblith, Si Pham, James Symes, Alan W Heldman

Circ Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis